POON CHRISTINE A — SEC insider filings

SEC reporting owner CIK 1189014. 75 insider filings on record with FilingPulse; latest filed 2026-11-04.

Transaction summary — filings shown

Covers the 50 most recent of 75 filings on record, filed 2022-08-11 to 2026-11-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
REGENERON PHARMACEUTICALS, INC. (REGN)Director9—26 legs · 52,448 sh · $44,021,41521
PRUDENTIAL FINANCIAL INC (PRU)Director22——67
SHERWIN WILLIAMS CO (SHW)Director14——14
NEUROCRINE BIOSCIENCES INC (NBIX)Director5——9

Insider filings — POON CHRISTINE A

FiledFormIssuerReported transactionsSource
2026-11-044REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 7,830 @ $376.69 · Sale (S): 218 @ $966.74 · Sale (S): 772 @ $967.38 · Sale (S): 2,499 @ $968.58 · Sale (S): 3,203 @ $969.50 · Sale (S): 937 @ $970.51 · +2 moreEDGAR
2026-09-144PRUDENTIAL FINANCIAL INC (PRU)Grant/award (A): 161 (derivative) @ $118.48 · Grant/award (A): 49 (derivative) @ $118.48 · Grant/award (A): 21 (derivative) @ $118.48EDGAR
2026-06-154PRUDENTIAL FINANCIAL INC (PRU)Grant/award (A): 177 (derivative) @ $106.51 · Grant/award (A): 54 (derivative) @ $106.51 · Grant/award (A): 23 (derivative) @ $106.51EDGAR
2026-05-294NEUROCRINE BIOSCIENCES INC (NBIX)Grant/award (A): 2,567 (derivative) @ $0EDGAR
2026-05-214NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 3,318 @ $0 · Option exercise (M): 3,318 (derivative) @ $0EDGAR
2026-05-144PRUDENTIAL FINANCIAL INC (PRU)Option exercise (M): 1,765 @ $0 · Disposition to issuer (D): 1,765 @ $102.58 · Grant/award (A): 1,754 (derivative) @ $0 · Option exercise (M): 1,765 (derivative) @ $0EDGAR
2026-03-164PRUDENTIAL FINANCIAL INC (PRU)Grant/award (A): 201 (derivative) @ $92.34 · Grant/award (A): 61 (derivative) @ $92.34 · Grant/award (A): 26 (derivative) @ $92.34EDGAR
2026-01-064REGENERON PHARMACEUTICALS, INC. (REGN)Grant/award (A): 155 @ $0 · Grant/award (A): 1,962 (derivative) @ $0EDGAR
2025-12-154PRUDENTIAL FINANCIAL INC (PRU)Grant/award (A): 151 (derivative) @ $117.05 · Grant/award (A): 46 (derivative) @ $117.05 · Grant/award (A): 19 (derivative) @ $117.05EDGAR
2025-10-314REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 6,500 @ $520.01 · Sale (S): 650 @ $652.68 · Sale (S): 2,735 @ $653.50 · Sale (S): 1,915 @ $654.42 · Sale (S): 100 @ $655.10 · Sale (S): 712 @ $656.50 · +4 moreEDGAR
2025-09-124PRUDENTIAL FINANCIAL INC (PRU)Grant/award (A): 163 (derivative) @ $106.99 · Grant/award (A): 50 (derivative) @ $106.99 · Grant/award (A): 21 (derivative) @ $106.99EDGAR
2025-06-164PRUDENTIAL FINANCIAL INC (PRU)Grant/award (A): 164 (derivative) @ $104.90 · Grant/award (A): 50 (derivative) @ $104.90 · Grant/award (A): 21 (derivative) @ $104.90EDGAR
2025-05-224NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 1,435 @ $0 · Grant/award (A): 3,318 (derivative) @ $0 · Option exercise (M): 1,435 (derivative) @ $0EDGAR
2025-05-154PRUDENTIAL FINANCIAL INC (PRU)Option exercise (M): 1,321 @ $0 · Disposition to issuer (D): 1,321 @ $107.40 · Grant/award (A): 1,675 (derivative) @ $0 · Option exercise (M): 1,321 (derivative) @ $0EDGAR
2025-04-074SHERWIN WILLIAMS CO (SHW)Grant/award (A): 4.11 @ $338.25EDGAR
2025-03-174PRUDENTIAL FINANCIAL INC (PRU)Grant/award (A): 162 (derivative) @ $105.04 · Grant/award (A): 49 (derivative) @ $105.04 · Grant/award (A): 16 (derivative) @ $105.04EDGAR
2025-02-204SHERWIN WILLIAMS CO (SHW)Grant/award (A): 517 @ $0EDGAR
2025-01-074SHERWIN WILLIAMS CO (SHW)Grant/award (A): 25.19 @ $335EDGAR
2025-01-064REGENERON PHARMACEUTICALS, INC. (REGN)Code (W): 14 @ $0 · Grant/award (A): 166 @ $0 · Grant/award (A): 1,958 (derivative) @ $0EDGAR
2024-12-164PRUDENTIAL FINANCIAL INC (PRU)Grant/award (A): 134 (derivative) @ $120.61 · Grant/award (A): 41 (derivative) @ $120.61 · Grant/award (A): 13 (derivative) @ $120.61EDGAR
2024-10-084SHERWIN WILLIAMS CO (SHW)Grant/award (A): 22.65 @ $372.47EDGAR
2024-09-164PRUDENTIAL FINANCIAL INC (PRU)Grant/award (A): 138 (derivative) @ $115.84 · Grant/award (A): 42 (derivative) @ $115.84 · Grant/award (A): 14 (derivative) @ $115.84EDGAR
2024-08-194REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 10,838 @ $413.33 · Sale (S): 1,012 @ $1,155.72 · Sale (S): 2,368 @ $1,156.30 · Sale (S): 1,560 @ $1,157.33 · Sale (S): 212 @ $1,158.02 · Sale (S): 5,352 @ $1,159.56 · +3 moreEDGAR
2024-07-094SHERWIN WILLIAMS CO (SHW)Grant/award (A): 28.55 @ $295.50EDGAR
2024-06-174PRUDENTIAL FINANCIAL INC (PRU)Grant/award (A): 139 (derivative) @ $113.97 · Grant/award (A): 42 (derivative) @ $113.97 · Grant/award (A): 14 (derivative) @ $113.97EDGAR
2024-05-234NEUROCRINE BIOSCIENCES INC (NBIX)Grant/award (A): 1,435 (derivative) @ $0 · Grant/award (A): 2,982 (derivative) @ $0EDGAR
2024-05-164PRUDENTIAL FINANCIAL INC (PRU)Grant/award (A): 1,261 (derivative) @ $0EDGAR
2024-05-134PRUDENTIAL FINANCIAL INC (PRU)Option exercise (M): 1,935 @ $0 · Disposition to issuer (D): 1,935 @ $117.95 · Option exercise (M): 1,935 (derivative) @ $0EDGAR
2024-04-094SHERWIN WILLIAMS CO (SHW)Grant/award (A): 25.45 @ $331.56EDGAR
2024-03-184PRUDENTIAL FINANCIAL INC (PRU)Grant/award (A): 140 (derivative) @ $111.74 · Grant/award (A): 43 (derivative) @ $111.74 · Grant/award (A): 22 (derivative) @ $111.74EDGAR
2024-02-154SHERWIN WILLIAMS CO (SHW)Grant/award (A): 594 @ $0EDGAR
2024-01-094SHERWIN WILLIAMS CO (SHW)Grant/award (A): 28.41 @ $296.96EDGAR
2024-01-044REGENERON PHARMACEUTICALS, INC. (REGN)Grant/award (A): 135 @ $0 · Grant/award (A): 1,607 (derivative) @ $0EDGAR
2023-12-184PRUDENTIAL FINANCIAL INC (PRU)Grant/award (A): 142 (derivative) @ $105.21 · Grant/award (A): 43 (derivative) @ $105.21 · Grant/award (A): 22 (derivative) @ $105.21EDGAR
2023-10-104SHERWIN WILLIAMS CO (SHW)Grant/award (A): 32.10 @ $253.15EDGAR
2023-09-184PRUDENTIAL FINANCIAL INC (PRU)Grant/award (A): 148 (derivative) @ $99.14 · Grant/award (A): 45 (derivative) @ $99.14 · Grant/award (A): 23 (derivative) @ $99.14EDGAR
2023-08-254REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 12,280 @ $273.67 · Sale (S): 300 @ $837.92 · Sale (S): 1,998 @ $838.60 · Sale (S): 3,032 @ $839.45 · Sale (S): 6,450 @ $840.65 · Sale (S): 500 @ $841.05 · +1 moreEDGAR
2023-07-134NEUROCRINE BIOSCIENCES INC (NBIX)Grant/award (A): 16,375 (derivative) @ $0EDGAR
2023-07-104SHERWIN WILLIAMS CO (SHW)Grant/award (A): 31.62 @ $257EDGAR
2023-06-204PRUDENTIAL FINANCIAL INC (PRU)Grant/award (A): 167 (derivative) @ $86.76 · Grant/award (A): 51 (derivative) @ $86.76 · Grant/award (A): 26 (derivative) @ $86.76EDGAR
2023-05-114PRUDENTIAL FINANCIAL INC (PRU)Option exercise (M): 1,517 @ $0 · Disposition to issuer (D): 1,517 @ $81.50 · Option exercise (M): 1,517 (derivative) @ $0 · Grant/award (A): 1,840 (derivative) @ $0EDGAR
2023-04-124SHERWIN WILLIAMS CO (SHW)Grant/award (A): 36.32 @ $223.68EDGAR
2023-03-204PRUDENTIAL FINANCIAL INC (PRU)Grant/award (A): 174 (derivative) @ $82.19 · Grant/award (A): 53 (derivative) @ $82.19 · Grant/award (A): 22 (derivative) @ $82.19EDGAR
2023-02-164SHERWIN WILLIAMS CO (SHW)Grant/award (A): 711 @ $0EDGAR
2023-01-104SHERWIN WILLIAMS CO (SHW)Grant/award (A): 34.92 @ $232.66EDGAR
2023-01-054REGENERON PHARMACEUTICALS, INC. (REGN)Grant/award (A): 165 @ $0 · Grant/award (A): 1,929 (derivative) @ $0EDGAR
2022-12-194PRUDENTIAL FINANCIAL INC (PRU)Grant/award (A): 136 (derivative) @ $99.75 · Grant/award (A): 41 (derivative) @ $99.75 · Grant/award (A): 17 (derivative) @ $99.75EDGAR
2022-10-114SHERWIN WILLIAMS CO (SHW)Grant/award (A): 38.80 @ $209.43EDGAR
2022-09-194PRUDENTIAL FINANCIAL INC (PRU)Grant/award (A): 145 (derivative) @ $92.54 · Grant/award (A): 44 (derivative) @ $92.54 · Grant/award (A): 18 (derivative) @ $92.54EDGAR
2022-08-114REGENERON PHARMACEUTICALS, INC. (REGN)Option exercise (M): 15,000 @ $177.82 · Sale (S): 6,814 @ $620.47 · Sale (S): 8,186 @ $621.27 · Option exercise (M): 15,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-26 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1189014 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs